Your browser doesn't support javascript.
loading
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.
Avogaro, A; Giaccari, A; Fioretto, P; Genovese, S; Purrello, F; Giorgino, F; Del Prato, S.
Afiliação
  • Avogaro A; a Department of Internal Medicine , University of Padova , Padova , Italy.
  • Giaccari A; b Università Cattolica del Sacro Cuore, Section of Endocrinology and Metabolic Diseases, Policlinico Gemelli , Rome , Italy.
  • Fioretto P; a Department of Internal Medicine , University of Padova , Padova , Italy.
  • Genovese S; c Department of Cardiovascular and Metabolic Diseases , IRCCS Multimedica , Sesto San Giovanni , Milan , Italy.
  • Purrello F; d Department of Biomedical Sciences and Biotechnology, Section of Biology and Genetics Giovanni Sichel , Unit of Biomolecular, Genome and Complex Systems Biomedicine , Catania , Italy.
  • Giorgino F; e Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation , University of Bari Aldo Moro , Bari , Italy.
  • Del Prato S; f Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy.
Expert Rev Clin Pharmacol ; 10(7): 763-772, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28431476
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Glucosídeos / Hipoglicemiantes Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Glucosídeos / Hipoglicemiantes Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article